• News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Xeloda

  • Treatment of Stage I – III Colon Cancer
    August 29, 2025

    Treatment of Stage I – III Colon Cancer

    Charles H. Weaver, MD
  • Ask the Experts About Circulating Tumor DNA in the Management of Colorectal Cancer
    August 9, 2024

    Ask the Experts About Circulating Tumor DNA in the Management of Colorectal Cancer

    Charles H. Weaver, MD
  • Low-Dose Xeloda After Surgery for Triple-Negative Breast Cancer Reduces Recurrence Risk
    April 23, 2021

    Low-Dose Xeloda After Surgery for Triple-Negative Breast Cancer Reduces Recurrence Risk

    Charles H. Weaver, MD
  • Tukysa (tucatinib) – HER2 Inhibitor for Treatment of Breast Cancer
    June 5, 2020

    Tukysa (tucatinib) – HER2 Inhibitor for Treatment of Breast Cancer

    Charles H. Weaver, MD
  • Oral Alternative for Treatment of Colon Cancer
    May 6, 2018

    Oral Alternative for Treatment of Colon Cancer

    Charles H. Weaver, MD
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
 

Loading Comments...